Non-antibiotic strategies for sepsis

Slides:



Advertisements
Similar presentations
Models for the organisation of hospital infection control and prevention programmes B. Gordts Clinical Microbiology and Infection Volume 11, Pages
Advertisements

Laboratory diagnosis and biosafety issues of biological warfare agents
Vaccines for the elderly
C.-S. Lee, J.-H. Lee  Clinical Microbiology and Infection 
P.-Y. Lévy  Clinical Microbiology and Infection 
L. Boyanova  Clinical Microbiology and Infection 
Benchmarking inappropriate empirical antibiotic treatment
G. Cornaglia, A. Lönnroth, M. Struelens 
Gut bacterial microbiota and obesity
Approach to diagnosis of infective endocarditis
Molecular characterization of methicillin-resistant Staphylococcus aureus isolated over a 2-year period in a Qatari hospital from multinational patients 
S. Wagenpfeil, A. Neiss, K. Banz, P. Wutzler 
Herpes zoster in non-hospitalized children
Migrant health—a cause for concern?
Clinical characteristics of Haemophilus influenzae meningitis in Denmark in the post- vaccination era  T.I. Pedersen, M. Howitz, C. Østergaard  Clinical.
Genomics of epidemic pathogens
C.-S. Lee, J.-H. Lee  Clinical Microbiology and Infection 
J.-P. Van geertruyden  Clinical Microbiology and Infection 
R. Cantón  Clinical Microbiology and Infection 
Genital Chlamydia trachomatis infections
P. Nordmann, L. Poirel  Clinical Microbiology and Infection 
Louis Pasteur, from crystals of life to vaccination
How to evaluate and predict the ecologic impact of antibiotics: the pharmaceutical industry view from research and development  R. Bax  Clinical Microbiology.
Should standardized susceptibility testing for microbial biofilms be introduced in clinical practice?  T. Coenye, D. Goeres, F. Van Bambeke, T. Bjarnsholt 
Surveillance of Legionnaires’ disease in Austria
How to evaluate and predict the epidemiologic impact of antibiotic use in humans: the pharmacoepidemiologic approach  D. Guillemot  Clinical Microbiology.
Diagnosing infections—current and anticipated technologies for point-of-care diagnostics and home-based testing  L. Bissonnette, M.G. Bergeron  Clinical.
Impact of antibiotic restrictions: the pharmaceutical perspective
Vector control: a cornerstone in the malaria elimination campaign
Breast milk causing neonatal sepsis and death
Training for the infectious diseases speciality in Norway
Laboratory diagnosis and biosafety issues of biological warfare agents
CMI editorial report 2011 Clinical Microbiology and Infection
Elements of design: the knowledge on which we build
Levofloxacin in the treatment of ventilator-associated pneumonia
G. Pappas  Clinical Microbiology and Infection 
Metagenomics and probiotics
Effect of antioxidants on the immune response of Helicobacter pylori
Laboratory diagnosis of Clostridium difficile disease
Recent developments in staphylococcal scalded skin syndrome
The practice of travel medicine in Europe
Systematic review of antibiotic consumption in acute care hospitals
Community-acquired pneumonia: epidemiologic and clinical consideration
Abstracts cont. Clinical Microbiology and Infection
Pandemic lineages of extraintestinal pathogenic Escherichia coli
Benchmarking inappropriate empirical antibiotic treatment
Training in infectious diseases and tropical medicine in Britain
Reducing antibiotic use in influenza: challenges and rewards
Fibronectin concentrations in catheter sepsis
Antimicrobial drug development – the past, the present, and the future
Vaccines for the elderly
Clinical infection services—the Leiden experience
Statin use and clinical outcomes among pneumonia patients
Clinical Microbiology and Infection
Clinical Microbiology and Infection
Evaluation of the performance of the Helico Blot 2
K. Kaier, N.T. Mutters, U. Frank  Clinical Microbiology and Infection 
Z. Erjavec, H. Kluin-Nelemans, P.E. Verweij 
Survival of rhinoviruses on human fingers
The atypical pneumonias: clinical diagnosis and importance
Facilitating learning and change in physicians: Implications for a system of continuing medical education in Europe  Robert D. Fox  Clinical Microbiology.
Abstracts Clinical Microbiology and Infection
Virology: a scientific discipline facing new challenges
Modelling during an emergency: the 2009 H1N1 influenza pandemic
J.L. Balcázar  Clinical Microbiology and Infection 
G.C. Schito  Clinical Microbiology and Infection 
Impact of antibiotic restrictions: the patient's perspective
Comparative study of pediculicidal effect of medical plants
CMI readers' survey Clinical Microbiology and Infection
The future of diagnostic bacteriology
Presentation transcript:

Non-antibiotic strategies for sepsis J. Cohen  Clinical Microbiology and Infection  Volume 15, Issue 4, Pages 302-307 (April 2009) DOI: 10.1111/j.1469-0691.2009.02753.x Copyright © 2009 European Society of Clinical Infectious Diseases Terms and Conditions

FIG. 1 Sepsis is driven by components of both the host and the bacterial pathogen. The molecular basis of both the microbial virulence factors and the host immune response have been extensively investigated and characterized. IR, immune response. Clinical Microbiology and Infection 2009 15, 302-307DOI: (10.1111/j.1469-0691.2009.02753.x) Copyright © 2009 European Society of Clinical Infectious Diseases Terms and Conditions

Feedback: Privacy Policy Feedback
Do Not Sell My Personal Information
About project: SlidePlayer Terms of Service

© 2024 SlidePlayer.com Inc. All rights reserved.